Researchers from the John Curtin School of Medical Research in Canberra, Australia have discovered that the insulin-producing beta cells need a complex sugar, heparan sulfate, for their survival and without it they die. Replacement of heparan sulfate in the beta cells rescues the cells from dying in culture and protects them from oxidative damage...

Novartis has decided to terminate the ALTITUDE study evaluating the potential benefits of Rasilez/Tekturna (aliskiren) in reduction of risk of cardiovascular and renal events in patients with type 2 diabetes and renal impairment...

JDRF announced it will support a pioneering diabetes research program that is developing a first-of-its-kind cell therapy for type 1 diabetes and other forms of insulin-dependent diabetes. The therapy is a combination product that packages immature cells made from human embryonic stem cells (hESCs) that over time develop into mature pancreatic hormone producing cells...